Innovation is headquartered in Beverly, Massachusetts. Our office address, phone and fax number can be found by visiting the Contact Us page of this website.
Innovation was incorporated in Nevada in 2007. It re-branded in 2017, and was formerly Cellceutix Corporation.
Innovation’s fiscal year-end is June 30th.
Baker Tilly Virchow Krause, LLP is Innovation’s independent accounting firm.
Innovation's legal counsel is Hogan Lovells, LLP.
Innovation is currently listed on the OTCQB exchange. Innovation went public in 2007.
Innovation is publicly traded under the ticker symbol "IPIX” on the OTCQB stock exchange.
Innovation does not pay dividends and does not anticipate doing so in the foreseeable future. It remains in a high-growth phase, requiring all available capital to be reinvested in business operations and scientific advancement.
Innovation's transfer agent is West Coast Stock Transfer, Inc.
If you have misplaced stock certificates, please contact our transfer agent. There may be a fee incurred for replacing lost stock certificates.
The CUSIP number for our common stock is: 45782D 100
Electronic copies of all regulatory filings are available by clicking on the Financials & Filings link in the Investors section of the website.
Candidates can inquire about job openings by visiting the Contact Us page of the website and selecting Careers on the submission form.
Please visit the Contact Us page of the website to submit additional questions or inquiries.